Search clinical trials for: Inotuzumab ozogamicin (INO)

Total 8289 results

University of Wisconsin, Madison
Radius Health, Inc.

Active, not recruiting

Abaloparatide Before Total Knee Arthroplasty

Osteoporosis | Arthroplasties, Knee Replacement

United States
National Cancer Centre, Singapore
Innogene Kalbiotech Pte. Ltd

Completed

Study of Nimotuzumab and Cisplatin/Radiotherapy for Locally Advanced Head and Neck Squamous Cell Cancer

Head and Neck Cancer

Singapore
John Quigley
Pfizer; AbbVie

Active, not recruiting

Study of the Safety and Efficacy of Gemtuzumab Ozogamicin (GO) and Venetoclax in Patients With Relapsed or Refractory CD33+ Acute Myeloid Leukemia:Big Ten Cancer Research Consortium BTCRC-AML17-113

Acute Myeloid Leukemia

United States
German Cancer Research Center
University Hospital Heidelberg; University Hospital Dresden

Not yet recruiting

Genetic Ablation of CD33 in HSC to Broaden the Therapeutic Index of CD33-directed Immunotherapy in Patients With AML (GALAXY33)

Relapsed/Refractory Acute Myeloid Leukemia (AML)

Germany
Brown University
Pfizer; The Miriam Hospital; Rhode Island Hospital

Active, not recruiting

Fractionated Gemtuzumab Ozogamicin Followed by Non-engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia

United States
New York Medical College

Completed

Immunochemotherapy and AlloSCT in Patients With High Risk CD33+ AML/MDS

Myelodysplastic Syndrome | Acute Myelogenous Leukemia

United States
Biotech Pharmaceutical Co., Ltd.

Not yet recruiting

Nimotuzumab Combined With Paclitaxel for Recurrent Metastatic Gastric or Esophagogastric Junction Adenocarcinoma (NOTABLE-307)

Gastric or Esophagogastric Junction Adenocarcinoma
Biotech Pharmaceutical Co., Ltd.

Unknown

Nimotuzumab in Combined With Paclitaxel and Cisplatin for Treatment of Metastatic Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinomas

China
Tenwek Hospital
National Cancer Institute (NCI); Mayo Clinic; Medtronic - MITG

Suspended

Endoscopic Prevention of Esophageal Cancer at Tenwek Hospital (EXPECT)

Esophageal Cancer | Esophageal Squamous Dysplasia

Kenya
Inovio Pharmaceuticals

Completed

A Study of DNA Vaccine With Electroporation for the Prevention of Disease Caused by H1 and H5 Influenza Virus

Healthy

United States
Shanghai Proton and Heavy Ion Center

Recruiting

Functional Image-Guided Carbon Ion Irradiation With Simultaneous Integrated Boost for Prostate Cancer

Localized Prostate Cancer

China
Vanderbilt University
American Association of Diabetes Educators

Completed

Addressing The Role of Nutrition Education & Health Literacy in Diabetes Care (DiNES)

Diabetes

United States
Weill Medical College of Cornell University

Unknown

Virtual Reality for Burn Wound Care Pain Control

Pain | Anxiety

United States
Radius Health, Inc.

Completed

Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Usability of Abaloparatide-solid Microstructured Transdermal System (sMTS) in Postmenopausal Women With Low Bone Mineral Density (BMD)

Postmenopausal Osteoporosis

United States
Hanlim Pharm. Co., Ltd.

Completed

To Evaluate the Efficacy and Safety of LuminoMark Injection in Patients With Nonpalpable Breast Lesions(Phase 3)

Breast Diseases

Korea, Republic of
Chinese PLA General Hospital

Unknown

Nimotuzumab Plus S1 Versus Placebo Plus S1 as Maintenance Treatment in Patients With Unresectable Pancreatic Cancer

Unresectable Pancreatic Cancer

China
Wake Forest University Health Sciences
Bristol-Myers Squibb; Atrium Health Levine Cancer Institute

Active, not recruiting

LCI-HEM-MYE-CRD-002: Carfilzomib-Revlimid-Dexamethasone-Elotuzumab in Relapsed/Refractory Multiple Myeloma

Multiple Myeloma

United States
Bristol-Myers Squibb

No longer available

Expanded Access to Elotuzumab (Empliciti) for Multiple Myeloma

Multiple Myeloma
Eurofarma Laboratorios S.A.

Withdrawn

Study Comparing Radiation Therapy and Chemotherapy With or Without Nimotuzumab (NICAP)

Carcinoma | Head and Neck Cancer

Brazil
Fudan University
RenJi Hospital; Shanghai Chest Hospital; Shanghai General Hospital, Shanghai... and other collaborators

Unknown

Chemoradiation With or Without Nimotuzumab in Treating Esophageal Cancer Patients Who Suffer With Recurrence in Regional Lymph Nodes After Esophagectomy (Nimotuzumab)

Esophageal Squamous Cell Carcinoma

China
Inotek Pharmaceuticals Corporation

Completed

A Dose-Escalation Study Designed to Evaluate the Tolerability, Safety, Pharmacokinetics (PK), and Efficacy of Chronic Topical Ocular Application of INO-8875 in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma

Ocular Hypertension | Glaucoma

United States
Bayer

Completed

Post Marketing Surveillance Study on Emselex After Launch in Germany

Overactive Bladder

Germany
Gruppo Italiano Malattie EMatologiche dell'Adulto

Recruiting

Gemtuzumab Chemotherapy MRD Levels; Glasdegib Post-transplant, Adult Untreated, de Novo, Fav Interm Risk AML

Acute Myeloid Leukemia

Italy
Raija Silvennoinen
Bristol-Myers Squibb; Amgen; Hospital District of Helsinki and Uusimaa

Completed

Carfilzomib + Elotuzumab + Dexamethasone for Relapsed Multiple Myeloma After 1-3 Prior Treatment Lines (KEd)

Multiple Myeloma in Relapse

Finland, Sweden
Medical University of Warsaw

Completed

Trial Comparing Proximal Tibia and Proximal Humerus Infusion Rates Using the NIO Intraosseous Device (IOACS)

Resuscitation | Intraosseous Access

Poland
University College, London
Pfizer; Cancer Research UK

Completed

Treatment of Patients With Diffuse Large B Cell Lymphoma Who Are Not Suitable for Anthracycline Containing Chemotherapy (INCA)

Diffuse Large B Cell Lymphoma

United Kingdom
Bionorica SE

Completed

Efficacy and Safety of a Herbal Medicinal Product (Dry Extract BNO 1016) in Patients With Acute Rhinosinusitis

Acute Rhinosinusitis

Germany
UNC Lineberger Comprehensive Cancer Center
National Cancer Institute (NCI); Genzyme, a Sanofi Company

Terminated

Clofarabine and Gemtuzumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Leukemia

United States
Wei Guo
Sun Yat-sen University

Completed

Nimotuzumab in Combination With TPF(Cisplatin ,Fluorouracil and Docetaxel) for Head and Neck Squamous Cell Carcinoma

Head and Neck Squamous Cell Carcinoma

China
Huons Co., Ltd.

Unknown

The Safety and Efficacy Study of Hutox Versus Botox® in Subject With Moderate to Severe Glabellar Lines

Glabellar Frown Lines

Korea, Republic of
Dr. Te Vuong
YM BioSciences

Terminated

Nimotuzumab With Radiotherapy in the Treatment of Anal Canal Cancers

Squamous Cell Carcinoma of Anal Canal

Canada
The First Affiliated Hospital with Nanjing Medical...

Enrolling by invitation

Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age

Esophageal Carcinoma

China
Hangzhou Cancer Hospital
Shanghai bokang bioengineering co., LTD

Unknown

Immunotherapy of Advanced Cancer Using a Combination Nimotuzumab and NK Cells

Advanced Cancer | ADCC | NK Cell Mediated Immunity | Nimotuzumab | Adaptive Transfer

China
Bristol-Myers Squibb

Completed

A Phase I Open Label Study of the Safety and Tolerability of Elotuzumab (BMS-901608) Administered in Combination With Either Lirilumab (BMS-986015) or Urelumab (BMS-663513) in Subjects With Multiple Myeloma

Multiple Myeloma

United States, Spain
Versailles Hospital

Completed

Gemtuzumab Ozogamicin+Cytarabine vs Idarubicin+Cytarabine in Elderly Patients With AML.Mylofrance 4 (ALFA1401)

Acute Myeloid Leukemia

France
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers

Stage IV Anal Cancer AJCC v8 | Recurrent Cervical Carcinoma | Metastatic Malignant Neoplasm | Stage IV Penile Cancer AJCC v8 | Recurrent Malignant Neoplasm | Refractory Malignant Neoplasm | Stage IV Cervical Cancer AJCC v8 | Stage IVA Cervical Cancer AJCC v8 | Stage IVB Cervical Cancer AJCC v8 | Stage... and other conditions

United States
St. Louis University

Completed

Effect of Huperzine A on Cognitive Function and Perception of Effort During Exercise

Cognitive Enhancement During Exercise

United States
Idera Pharmaceuticals, Inc.

Completed

A 12-week Dose-Ranging Trial in Patients With Moderate to Severe Plaque Psoriasis (8400-201)

Plaque Psoriasis

Netherlands
Inovio Pharmaceuticals
Coalition for Epidemic Preparedness Innovations

Completed

Safety, Tolerability and Immunogenicity of INO-4700 for MERS-CoV in Healthy Volunteers

Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

Lebanon, Jordan, Kenya
Inotek Pharmaceuticals Corporation

Completed

Phase I Dose-Escalation Study to Evaluate Tolerability, Safety & PK of INO-8875 in Healthy Older-Adult Volunteers

Health

United States
University of South Florida

Completed

Enhanced Pharmacist-Managed Anticoagulation Service in a University-based Family Medicine Clinic

Anticoagulation | Home INR Monitoring
University of Dundee

Completed

Effect of Intermittent Pressure in Patients With PAD

Peripheral Arterial Disease

United Kingdom
Washington University School of Medicine

Completed

Abscess Packing Versus Wick Placement After Incision and Drainage

Superficial Abscess Packing

United States
Seoul National University Hospital

Completed

Comparison of NEOVIST 370 INJ.(Iopromide 768.86mg) With Ultravist 370 INJ.(Iopromide 768.86mg) in Abdominal CT

Abdominal CT
Ono Pharma USA Inc

Completed

Placebo-Controlled Study of ONO-2333Ms in Patients With Recurrent Major Depressive Disorder

Major Depressive Disorder

United States
Huons Co., Ltd.

Completed

The Safety and Efficacy Study of HU-014 Versus Botox® in Subject With Moderate to Severe Glabellar Lines

Glabellar Lines

Korea, Republic of
EHL Bio Co., Ltd.

Completed

Safety and Efficacy of ADSTEM Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis

Atopic Dermatitis

Korea, Republic of
M.D. Anderson Cancer Center

Completed

Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia and High-risk Myelodysplastic Syndrome

Myelodysplastic Syndrome | Acute Myelogenous Leukemia

United States
Radboud University Medical Center
Bristol-Myers Squibb

Active, not recruiting

Ipilimumab With Nivolumab for Molecular-selected Patients With Castration-resistant Prostate Cancer (INSPIRE)

Prostatic Neoplasms, Castration-Resistant

Netherlands
Zhejiang University

Withdrawn

Nimotuzumab Plus Nab-paclitaxel and Cisplatin in Treating Patients With Advanced Esophageal Carcinoma

Stage IV Esophageal Squamous Cell Carcinoma

China

3

Subscribe